S-1 · primary offering
Issued 2021
Proposed maximum
Shares registered
- Filed
- Effective
RLYB$15.99+1.46%
Rallybio Corp
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$86.75M
Float & O/S:
Inst Own:
DilutionScan read 44 of Rallybio Corp's SEC filings and found 1 warrant series, 1 ATM program, 2 shelf registrations and 1 S-1 registration on file for RLYB. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 1, 2026.
Signal8 Summary
Raise routes on file: effective shelf · latest dilution event 34 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
November 2022 follow-on offering pre-funded warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2022
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Know who's about to sell into your RLYB trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
